Stay updated on Doxorubicin in Advanced Hepatocellular Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Doxorubicin in Advanced Hepatocellular Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Doxorubicin in Advanced Hepatocellular Carcinoma Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page’s revision tag was updated from v3.5.4 to v3.5.5, signaling a minor site update; no study content or navigation elements appear to be changed.
    Difference
    0.0%
    Check dated 2026-06-08T04:13:05.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    Revision tag updated from v3.5.3 to v3.5.4. This indicates a patch-level update to the page's documentation or content.
    Difference
    0.0%
    Check dated 2026-05-17T09:18:37.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    The page’s technical revision/version tag was updated from v3.5.0 to v3.5.3 without changing the study details.
    Difference
    0.0%
    Check dated 2026-04-25T17:56:54.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    RELIVE trial publication citation added (Lancet Gastroenterol Hepatol, 2019) and the related erratum entry removed.
    Difference
    0.0%
    Check dated 2026-04-04T05:50:00.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    Adds the term 'Hepatocellular carcinoma' to the page content and includes the Genetic and Rare Diseases Information Center as a resource. Updates the site revision from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-20T20:23:00.000Z thumbnail image
  8. Check
    97 days ago
    Change Detected
    Summary
    Added the RELIVE publication citation (Lancet Gastroenterol Hepatol 2019) with revision v3.4.3 and removed the earlier v3.4.2 citation.
    Difference
    0.1%
    Check dated 2026-03-06T18:11:26.000Z thumbnail image

Stay in the know with updates to Doxorubicin in Advanced Hepatocellular Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Doxorubicin in Advanced Hepatocellular Carcinoma Clinical Trial page.